AT
National Institute of Immunology, New Delhi, India
17-20 November, 2008
Organizers
Dr Avadhesha Surolia, Ph.D.
Director, National Institute of Immunology, New Delhi 110067, India
Dr Brian Wigdahl, Ph.D.
Professor & Chair Department of Microbiology and Immunology, and Director, Institute for Molecular Medicine and Infectious Disease,
Drexel University College of Medicine, Philadelphia, PA 19102, USA
Dr Zafar Khan, Ph.D.
Professor, Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA
Program Details
The National Institute of Immunology, New Delhi is hosting its first Joint Symposium with Drexel University, Philadelphia, PA and Scientists from other institutes of USA, with the focus on Infectious Diseases, Neuropathogenesis, Structural Biology, Microbicides, Biomedical Engineering, Molecular Diagnostics, Nanotechnology and Translational Medicine etc. We wish to develop a 3 + 1/2 day program and expect about 100 delegates from various countries. State of the Art lectures will be organized on Infectious Diseases that are a major public health problem in India. They include viral diseases (HIV, HTLV, Hepatitis); bacterial and parasitic diseases (Mycobacterium tuberculosis, Malaria, other bacterial pathogens etc). Besides, latest translational trends on diagnostics, therapeutics, vaccines, microbicides and bioinformatics will be covered by national and international experts. Approximately 25 speakers from USA and 30 speakers from India who are leaders in their subject areas will present their work and discuss the possibility of developing target based interventions. This meeting will allow opportunities for developing collaborations for increasing research outputs and provide novel translational avenues.
We are planning about 50 talks on the following Sessions and extensive discussions will be carried out after each session
1. Basic Neuroscience and neurodegenerative diseases
2. Innate and Adaptive immune responses
3. HIV/AIDS Molecular Pathogenesis
4. Malaria – invasion motor, entry and pathogenesis.
5. Hepatitis, biomarker and therapeutic targets
6. Mycobaterium tuberculosis – pathogenesis and translational approaches
7. HIV/AIDS molecular therapeutics, vaccines and microbicides
8. Nanotechnology and Translational Medicine
9. Infectious Diseases and Bioinformatics
10. HIV/AIDS Substance abuse and Co-morbidity pathogens
11. Nosocomial infections and microbial resistance
12. Biomedical Engineering & Molecular Diagnostics
0 Comments